Avalere is pleased to announce the promotion of three leaders in its Evidence & Strategy and Market Access practices.
Elizabeth Carpenter will step down as Avalere President. Sarah Alwardt will lead Avalere on an interim basis.
Emily Lobelo, who has served for 15 years at the CDC, brings extensive knowledge of the vaccine landscape to Avalere’s policy team.
As a strategic advisor to the Policy Practice, Lisa Joldersma adds deep expertise in Medicare, commercial and employer-based insurance, and state policy issues.
As a new managing director in the Evidence & Strategy practice, Laura Housman brings deep expertise in the pharmaceutical, device, and healthcare industries.
Shareef Ghanem rejoins Avalere as a managing director, bringing more than 10 years of experience in due diligence, operations, and corporate strategy.
The veteran health policy professional brings expertise in coverage, access, and reimbursement and experience working with providers, plans, and manufacturers.
Veteran health policy professional brings deep expertise in value assessment, pharmaceutical value-based pricing, and payment reform.
Avalere Health welcomes Mandar Karhade, who supports healthcare outcomes research and data commercialization through innovation and advanced technology.
Global Malnutrition Composite Score Included in Inpatient Prospective Payment System Final Rule
UK-based Fishawack Health, a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries, released the following statement about the addition of Avalere Health to its group.
Avalere Health’s Market Access practice expands its team with recent hires bringing analytics, coverage strategy, and commercialization expertise.
Sean brings more than 2 decades of Medicare Advantage experience in industry and government.
Avalere Health welcomes Alex (Shuang) Du as an associate principal to its Market Access practice. He will support a variety of Avalere’s clients in navigating the evolving healthcare landscape.
New hire brings years of access, reimbursement, and revenue-cycle experience, strengthening Avalere's Market Access practice.
Sarah Alwardt joins Avalere as the practice director of the Center for Healthcare Transformation.
Two new additions expand expertise in drug pricing, payer engagement, CMS coverage and payment, and strategic market access and commercialization.
Seasoned health policy professional brings significant expertise in federal legislation, drug pricing policy, delivery system reform, and federal and state programs that affect insurance coverage.
Luke Reardon has joined Avalere’s Financial Services Practice as principal, bringing with him 15 years of experience that ranges from financial consulting to pharmacy solutions strategies.
They bring more than 35 years of combined healthcare experience and expertise in the immunization development sector.